Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice a meaningful reduction in hunger within the first one to four weeks of starting Mounjaro, though the full appetite-suppressing effect tends to build across the titration schedule as your dose increases. That shift is rarely a sudden off switch. It arrives gradually, and the timing varies from person to person depending on dose, biology, and what you eat. Mounjaro (tirzepatide) is a prescription-only medicine, and a GPhC-registered prescriber assesses clinical suitability before any treatment begins — because getting the titration right is part of how the appetite effect actually works. How Mounjaro affects hunger signals is a question worth understanding fully before you start, so the experience makes sense when it arrives.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people starting Mounjaro expect hunger to disappear within days. That expectation is understandable, the mechanism sounds dramatic, and the trial results are striking. But the more useful frame is this: you're not waiting for one moment when appetite switches off. You're watching a gradual shift unfold across weeks, shaped by where you are in the dose schedule.
Tirzepatide activates both GLP-1 and GIP receptors, which together slow how quickly food leaves your stomach and strengthen the signals your gut sends to your brain about fullness. Those effects accumulate. At 2.5 mg, the job of the first pen is largely to let your digestive system settle, nausea, if it appears, is most common here, and the appetite reduction is often subtle. Many people describe the first few weeks as a quiet version of what comes later.
After moving to 5 mg and beyond, a larger proportion of people report a more marked change: earlier fullness at meals, less preoccupation with food between them, and a general easing of the pull toward eating. For some that happens quickly; for others it takes another dose step. Mounjaro's mechanism and licensed use in the UK is covered in full on our treatment page if you want the wider picture. The point is that the titration is not just a safety formality, it is the process by which the appetite effect grows.
The first sign most people notice is not an absence of hunger exactly, but a change in what hunger feels like. The urgent, almost anxious pull toward eating softens. Meals feel satisfying sooner. Whether that registers in week one, week three, or week five depends on individual biology and, significantly, on the dose you're at.
There is a common misconception worth naming here: some people assume that if they don't feel dramatically less hungry in the first fortnight, the medicine isn't working. That isn't necessarily true. The trial evidence from the SURMOUNT programme, published in the New England Journal of Medicine, enrolled thousands of adults and showed that meaningful weight reduction accumulated steadily over 72 weeks, not all in the first month. Appetite suppression and the downstream weight effect are both gradual, dose-dependent processes.
Later in the titration, at 10 mg and above, the appetite effect is typically more pronounced, and some people find that food simply holds less mental space than it used to. That can feel unfamiliar, and it's worth knowing it's expected. What to make of hunger patterns while on Mounjaro has more detail on interpreting what you're experiencing day to day.
Because Mounjaro is injected once a week, its concentration in your body peaks shortly after the injection and tapers through the following days. Some people notice appetite returning noticeably in the 24 to 48 hours before their next dose. This is a pharmacokinetic pattern, not a sign of failure.
If that dip feels significant, diet composition can make a real difference across the week. Protein and fibre are particularly important on Mounjaro because appetite suppression can reduce total food intake enough that nutritional shortfalls become a genuine concern. What to eat on Mounjaro goes into this practically. The NHS guidance on weight-management medicines also emphasises that dietary support alongside treatment is part of how outcomes are sustained, it is not optional background noise.
If hunger remains largely unchanged after four or more weeks at a given dose, or if you feel it worsening, raise it with your prescriber before adjusting anything yourself. Dose timing, injection technique, dietary patterns, and individual metabolism can all play a role, none of which is straightforward to troubleshoot without clinical input. Our guide to persistent hunger on Mounjaro covers the specific reasons this happens and what questions are worth asking. For a review of cost alongside the clinical picture, Mounjaro pricing in the UK sets out what's included in a private prescription.
There is no single right answer to when hunger will ease. The NHS tirzepatide information notes that individual response varies, and prescribers routinely see people who feel the effect strongly from week two and others who only notice it clearly after their third dose step. Both are within normal range. NHS guidance on tirzepatide covers what to watch for and when to seek advice.
What is not a good plan: raising your own dose early hoping to speed up the effect, or concluding the medicine has failed before reaching a therapeutic dose. The prescriber-led titration schedule exists because moving too fast increases the risk of side effects without proportionately improving outcomes.
If you have concerns at any point in treatment (hunger, side effects, or simply wanting to understand where you are in the process) that is exactly what clinical aftercare is for. At nume, prescribers are available seven days a week. Persistent hunger on tirzepatide and why some people still feel hungry are both worth reading alongside this page. If you'd like to discuss your own timeline with a clinician, speaking to our prescribers is straightforward to arrange.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.